Is there a role for MR-guided focused ultrasound in Parkinson's disease?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is there a role for MR-guided focused ultrasound in Parkinson's disease?
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 33, Issue 4, Pages 575-579
Publisher
Wiley
Online
2018-02-24
DOI
10.1002/mds.27308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noninvasive neuromodulation and thalamic mapping with low-intensity focused ultrasound
- (2018) Robert F. Dallapiazza et al. JOURNAL OF NEUROSURGERY
- Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study
- (2018) Raul Martínez-Fernández et al. LANCET NEUROLOGY
- Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume
- (2017) Meaghan A. O'Reilly et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Current applications and limitations of surgical treatments for movement disorders
- (2017) Paul Krack et al. MOVEMENT DISORDERS
- Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson’s Disease Model
- (2017) Brian P. Mead et al. NANO LETTERS
- MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes
- (2017) Alfonso Fasano et al. NEUROLOGY
- Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound
- (2017) Charissa Poon et al. NEUROPHARMACOLOGY
- Comparative Evaluation of Magnetic Resonance-Guided Focused Ultrasound Surgery for Essential Tremor
- (2017) Minsoo Kim et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease
- (2017) Aaron E. Bond et al. JAMA Neurology
- Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model
- (2016) Chung-Yin Lin et al. JOURNAL OF CONTROLLED RELEASE
- Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound
- (2016) Brian P. Mead et al. JOURNAL OF CONTROLLED RELEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy
- (2016) Kullervo Hynynen et al. PHYSICS IN MEDICINE AND BIOLOGY
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound
- (2016) Alexandre Carpentier et al. Science Translational Medicine
- Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor
- (2016) Hong Chen et al. Scientific Reports
- Noninvasive, Targeted and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
- (2016) Ching-Hsiang Fan et al. Scientific Reports
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Current disease modifying approaches to treat Parkinson’s disease
- (2015) Dan Lindholm et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Focused ultrasound-mediated drug delivery through the blood–brain barrier
- (2015) Alison Burgess et al. Expert Review of Neurotherapeutics
- Enhanced Delivery and Bioactivity of the Neurturin Neurotrophic Factor through Focused Ultrasound—Mediated Blood—Brain Barrier Opening in vivo
- (2015) Gesthimani Samiotaki et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
- (2015) R.T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Unilateral magnetic resonance–guided focused ultrasound pallidotomy for Parkinson disease
- (2015) Young Cheol Na et al. NEUROLOGY
- Focused ultrasound-mediated drug delivery through the blood–brain barrier
- (2015) Alison Burgess et al. Expert Review of Neurotherapeutics
- Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
- (2015) Analiz Rodriguez et al. Pharmaceutics
- Osmotic nephrosis with mannitol: review article
- (2014) Ali Zohair Nomani et al. RENAL FAILURE
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound
- (2013) Po-Hung Hsu et al. PLoS One
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood–brain barrier using focused ultrasound and microbubbles
- (2012) Babak Baseri et al. PHYSICS IN MEDICINE AND BIOLOGY
- A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
- (2012) Sachiko Ohshima-Hosoyama et al. PLoS One
- Targeted Delivery of GDNF through the Blood–Brain Barrier by MRI-Guided Focused Ultrasound
- (2012) Feng Wang et al. PLoS One
- Targeted Delivery of Neural Stem Cells to the Brain Using MRI-Guided Focused Ultrasound to Disrupt the Blood-Brain Barrier
- (2011) Alison Burgess et al. PLoS One
- Influence of Exposure Time and Pressure Amplitude on Blood−Brain-Barrier Opening Using Transcranial Ultrasound Exposures
- (2010) Rajiv Chopra et al. ACS Chemical Neuroscience
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin Receptor
- (2009) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
- (2009) Jens Volkmann et al. MOVEMENT DISORDERS
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now